95 related articles for article (PubMed ID: 2936220)
1. [Experiences with the macrophage adherence inhibition test within the framework of preparing tumor-associated antigens from human breast cancers].
Bendix U; Bendix U
Allerg Immunol (Leipz); 1985; 31(4):273-82. PubMed ID: 2936220
[TBL] [Abstract][Full Text] [Related]
2. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].
Kharkevich DD; Polevaia EB; Derevnina NA; Sablikova IuA; Savinov AIu
Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405
[TBL] [Abstract][Full Text] [Related]
3. [Reaction of inhibition of macrophage electrophoretic mobility in differential diagnosis of carcinomas].
Miuller M; Irmsher Iu; Fisher R; Grosmann G
Vopr Onkol; 1976; 22(12):43-50. PubMed ID: 1020256
[TBL] [Abstract][Full Text] [Related]
4. Reactivity of serum-armed xenogeneic macrophages to breast cancer antigens.
Harris LF; Miller LL; Hickok DF
Cancer Res; 1982 Dec; 42(12):4985-90. PubMed ID: 7139603
[TBL] [Abstract][Full Text] [Related]
5. Detection of anti-tumor immunity in man by the indirect macrophage adherence inhibition assay using guinea pig peritoneal cells as indicator cells.
Schimke R; Ambrosius H
Neoplasma; 1981; 28(1):103-10. PubMed ID: 7279053
[TBL] [Abstract][Full Text] [Related]
6. [Pre- and postoperative reactivity of breast cancer patients to tumor associated antigens and HEP in the macrophage electrophoresis mobility (MEM) test].
Ladusch M; Schäffner H; Ullmann L; Littmann M; Reimann S; Gindl P; Ambrosius H
Arch Geschwulstforsch; 1982; 52(6):469-78. PubMed ID: 6186223
[TBL] [Abstract][Full Text] [Related]
7. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay.
Shenouda G; Thomson DM
Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of an immunoradiometric assay for CA15-3 antigen associated with human mammary carcinomas: comparison with carcinoembryonic antigen.
Fujino N; Haga Y; Sakamoto K; Egami H; Kimura M; Nishimura R; Akagi M
Jpn J Clin Oncol; 1986 Dec; 16(4):335-46. PubMed ID: 3467106
[TBL] [Abstract][Full Text] [Related]
9. Serologic detection of breast cancer.
Estes NC; Boehm OR; Jewell WR; Humphrey LJ
Bull Soc Int Chir; 1974 Mar; 33(2):85-90. PubMed ID: 4210924
[No Abstract] [Full Text] [Related]
10. Macrophage migration inhibition factor test in breast tumors.
Gutman H; Kott I; Rabinerson D; Reiss R
Isr J Med Sci; 1986 Nov; 22(11):812-6. PubMed ID: 3793437
[TBL] [Abstract][Full Text] [Related]
11. The fundamental and diagnostic role of T and Tn antigens in breast carcinoma at the earliest histologic stage and throughout.
Springer GF; Desai PR; Robinson MK; Tegtmeyer H; Scanlon EF
Prog Clin Biol Res; 1986; 204():47-70. PubMed ID: 2421349
[No Abstract] [Full Text] [Related]
12. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
Tsang PH; Holland JF; Bekesi JG
J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
[TBL] [Abstract][Full Text] [Related]
13. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
14. [Human antitumor immunity according to leukocyte adherence inhibition test data].
Riatsep VI; Kurtenkov OA; Nikitin IuG; Miliukhina LM
Vopr Onkol; 1980; 26(8):3-8. PubMed ID: 6998116
[TBL] [Abstract][Full Text] [Related]
15. [Expression of antigens immunologically related to the antigens of the mouse mammary tumor virus in the tissue of human breast tumors].
Remennik LV; Litvinov SV; Kriukova IN; Chuev IuV
Biull Eksp Biol Med; 1985 Jun; 99(6):734-6. PubMed ID: 2990606
[TBL] [Abstract][Full Text] [Related]
16. [Immunologic studies using the leukocyte adherence inhibition test in the diagnosis and postoperative follow-up of breast cancer].
Storch H; Granetzny A
Z Gesamte Inn Med; 1987 Jan; 42(2):41-4. PubMed ID: 3554795
[TBL] [Abstract][Full Text] [Related]
17. Superoxide assay-leukocyte adherence inhibition test and a soluble factor which stimulates the adherence of macrophages.
Yagawa K; Kaku M; Manabe H; Yasumoto K; Mashiba H; Iribe H; Yamagata J; Takenaka K; Nomura Y
Cancer Res; 1980 Dec; 40(12):4791-5. PubMed ID: 6254653
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas.
North SM; Steck PA; Nicolson GL
Cancer Res; 1986 Dec; 46(12 Pt 1):6393-9. PubMed ID: 3779654
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the LAI test in patients with benign and malignant breast diseases.
Kovarík J; Lauerová L; Ninger E; Munzarová M; Feit J; Zemanová D; Wotke R
Neoplasma; 1983; 30(2):163-7. PubMed ID: 6843721
[TBL] [Abstract][Full Text] [Related]
20. Morphologic assessment of reactivity to monoclonal antibodies generated against breast cancer cells in mammary tissues removed for clinical dysplasia or cancer.
Nuti M; Castagna M; Squartini F
Appl Pathol; 1984; 2(3):117-27. PubMed ID: 6085790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
